Fierce Pharma

Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'

The FDA has reprimanded Bayer for the “attention-grabbing visuals” and “frequent scene changes” in ads for the company’s ...
Medical Marketing & Media

Fresh off ruling in J&J case, Bayer’s Nubeqa ad runs afoul of FDA

Bayer received an FDA Untitled Letter this week for its prostate cancer drug Nubeqa, shortly after it launched a lawsuit ...
JD Supra

FDA Continues Crack Down on DTC Advertising: Untitled Letter Highlights Pitfalls in Schizophrenia Drug Promotion

Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...
Insider Monkey

ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement

ImmunityBio Inc. (NASDAQ:IBRX) is one of the best high growth healthcare stocks to buy now. On March 24, the FDA posted a warning letter to its site, stating that its Office of Prescription Drug ...
The National Law Review

FDA Continues Crack Down on DTC Advertising- Untitled Letter Highlights Pitfalls in Schizophrenia Drug Promotion

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...